Healthcare -
Biotechnology - NASDAQ - US
$ 3.34
2.77 %
$ 213 M
Market Cap
-2.9
P/E
LRMR - SELLING, GENERAL & ADMINISTRATIVE
Selling, General & Administrative LRMR - Larimar Therapeutics, Inc.
14.1 M
LAST VALUE
8.04%
2 YEAR CAGR
1.73%
5 YEAR CAGR
12.85%
10 YEAR CAGR